Physician Understanding and Willingness to Prescribe Biosimilars: Findings from a US National Survey.
Allison R KolbeAaron KearsleyLubna MerchantEva TemkinArchita PatelJing XuAmber JessupPublished in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2021)
Gaps in prescriber knowledge and hesitancy toward biosimilars remain significant challenges for biosimilar uptake. While formulary status of a biosimilar product strongly influences prescriber choice, additional prescriber education on biosimilarity is needed.